Simultaneous presence of lung adenocarcinoma and malignant pleural mesothelioma: A case report

被引：1

作者：

Yamazoe, Masatoshi ^{[1
]}

Tomioka, Hiromi ^{[1
]}

Kamada, Takahiro ^{[2
]}

Kaneko, Masahiro ^{[1
]}

Katsuyama, Eiji ^{[3
]}

机构：

[1] Kobe City Med Ctr West Hosp, Dept Resp Med, Kobe, Hyogo, Japan

[2] Natl Canc Ctr, Div Canc Immunol, Res Inst EPOC, Chiba, Japan

[3] Kobe City Med Ctr West Hosp, Dept Pathol, Kobe, Hyogo, Japan

来源：

RESPIRATORY MEDICINE CASE REPORTS | 2019年 / 26卷

关键词：

Malignant pleural mesothelioma; Lung cancer; Multiple primary cancer; Simultaneous; Autopsy; CELL CARCINOMA; PHASE-III; CONCURRENT MESOTHELIOMA; PROGNOSTIC-FACTORS; DIAGNOSIS; EXPRESSION; GUIDELINES; CISPLATIN; SURVIVAL; PATIENT;

D O I：

10.1016/j.rmcr.2018.11.011

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

The co-presence of malignant pleural mesothelioma (MPM) and lung cancer is rare. We report a 70-year-old male with exposure to asbestos. Chest computed tomography revealed a right mediastinal mass combined with an enlarged ipsilateral lymph node and left pleural effusion. Transbronchial lung biopsy revealed lung adenocarcinoma. Thoracoscopic examination revealed multiple left pleural nodules, leading to the diagnosis of MPM. Despite aggressive anticancer drug therapy, he expired due to disease progression 2.5 years after diagnosis. Autopsy confirmed an epithelioid MPM in the left pleura. MPM comorbidity in patients diagnosed with lung cancer should be considered, especially in those exposed to asbestos.

引用

页码：45 / 49

页数：5

共 35 条

[1] Allen TC, 2006, ARCH PATHOL LAB MED, V130, P721
[2] Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals
Attanoos, RL
Thomas, DH
Gibbs, AR
[J]. HISTOPATHOLOGY, 2003, 43 (04) : 387 - 392
[3] Bianchi C, 2007, TUMORI J, V93, P19
[4] Cagle PT, 2005, ARCH PATHOL LAB MED, V129, P1421
[5] CAGLE PT, 1993, MODERN PATHOL, V6, P438
[6] Analysis of Expression of Programmed Cell Death 1 Ligand 1 (PD-L1) in Malignant Pleural Mesothelioma (MPM)
Cedres, Susana
Ponce-Aix, Santiago
Zugazagoitia, Jon
Sansano, Irene
Enguita, Ana
Navarro-Mendivil, Alejandro
Martinez-Marti, Alex
Martinez, Pablo
Felip, Enriqueta
[J]. PLOS ONE, 2015, 10 (03):
[7] Prognostic factors in patients with pleural mesothelioma: The European Organization for Research and Treatment of Cancer experience
Curran, D
Sahmoud, T
Therasse, P
van Meerbeeck, J
Postmus, PE
Giaccone, G
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 145 - 152
[8] Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems
Edwards, JG
Abrams, KR
Leverment, JN
Spyt, TJ
Waller, DA
O'Byrne, KJ
[J]. THORAX, 2000, 55 (09) : 731 - 735
[9] Spontaneous Pneumothorax and Lung Carcinoma Should One Consider Synchronous Malignant Pleural Mesothelioma?
Flood, Trevor A.
Sekhon, Harman S.
Seely, Jean M.
Shamji, Farid M.
Gomes, Marcio M.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (06) : 770 - 772
[10] Positron emission tomography predicts survival in malignant pleural mesothelioma
Flores, Raja M.
Akhurst, Timothy
Gonen, Mithat
Zakowski, Maureen
Dycoco, Joseph
Larson, Steven M.
Rusch, Valerie W.
[J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2006, 132 (04) : 763 - 768

← 1 2 3 4 →